Arterra Bioscience's (BIT:ARBS) Dividend Will Be Increased To €0.13
Apr 15
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Biotech Industry Analysis
UpdatedApr 18, 2025
DataAggregated Company Financials
Companies3
- 7D5.1%
- 3M10.2%
- 1Y11.0%
- YTD7.7%
Over the last 7 days, the Biotech industry has risen 4.6%, driven by gains from every company within the industry. This means that the industry has gained 12% over the past year. As for the next few years, earnings are forecast to decline by 112% per annum.
Industry Valuation and Performance
Has the Italian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 18 Apr 2025 | €868.0m | €82.1m | €40.7m | 14.8x | 21.3x | 10.6x |
| Sun, 16 Mar 2025 | €793.6m | €8.0m | -€34,970,729.00 | 10.4x | -22.7x | 99.4x |
| Tue, 11 Feb 2025 | €760.4m | €8.0m | -€34,970,729.00 | 9.5x | -21.7x | 95.2x |
| Thu, 09 Jan 2025 | €790.6m | €8.0m | -€34,970,729.00 | 10x | -22.6x | 99x |
| Sat, 07 Dec 2024 | €786.2m | €8.0m | -€34,970,729.00 | 9.6x | -22.5x | 98.5x |
| Mon, 04 Nov 2024 | €820.9m | €8.0m | -€34,970,729.00 | 9.7x | -23.5x | 102.8x |
| Wed, 02 Oct 2024 | €840.5m | €7.3m | -€33,069,696.00 | 12x | -25.4x | 114.8x |
| Fri, 30 Aug 2024 | €897.7m | €28.1m | -€9,881,696.00 | 13x | -90.8x | 31.9x |
| Sun, 28 Jul 2024 | €877.2m | €28.1m | -€9,881,696.00 | 12.5x | -88.8x | 31.2x |
| Tue, 25 Jun 2024 | €840.1m | €29.3m | -€9,973,872.00 | 13.5x | -84.2x | 28.6x |
| Thu, 23 May 2024 | €781.5m | €29.5m | -€9,973,872.00 | 13.4x | -78.4x | 26.5x |
| Sat, 20 Apr 2024 | €778.4m | €29.4m | -€6,852,735.00 | 12.9x | -113.6x | 26.5x |
| Mon, 18 Mar 2024 | €750.1m | €33.9m | -€375,735.00 | 1123.3x | -1996.3x | 22.1x |
| Wed, 14 Feb 2024 | €724.2m | €33.9m | -€375,735.00 | 1080.9x | -1927.4x | 21.4x |
| Fri, 12 Jan 2024 | €765.4m | €33.9m | -€375,735.00 | 1138x | -2037x | 22.6x |
| Sun, 10 Dec 2023 | €749.0m | €33.9m | -€375,735.00 | 1150.7x | -1993.5x | 22.1x |
| Tue, 07 Nov 2023 | €750.1m | €33.9m | -€375,735.00 | 1154x | -1996.4x | 22.1x |
| Thu, 05 Oct 2023 | €497.9m | €33.8m | €1.3m | 11.5x | 383x | 14.7x |
| Sat, 02 Sep 2023 | €509.4m | €31.9m | -€5,269,721.00 | 9.9x | -96.7x | 16x |
| Mon, 31 Jul 2023 | €488.0m | €31.9m | -€5,269,721.00 | 10.7x | -92.6x | 15.3x |
| Wed, 28 Jun 2023 | €483.9m | €32.4m | -€5,269,721.00 | 11.5x | -91.8x | 14.9x |
| Fri, 26 May 2023 | €465.3m | €32.4m | -€5,269,721.00 | 10.3x | -88.3x | 14.4x |
| Sun, 23 Apr 2023 | €464.1m | €32.4m | -€5,269,721.00 | 11.8x | -88.1x | 14.3x |
| Tue, 21 Mar 2023 | €480.4m | €28.7m | -€4,740,218.00 | 10.9x | -101.3x | 16.7x |
| Thu, 16 Feb 2023 | €493.2m | €28.7m | -€4,740,218.00 | 12.2x | -104.1x | 17.2x |
| Sat, 14 Jan 2023 | €431.5m | €28.7m | -€4,740,218.00 | 11.1x | -91x | 15x |
| Mon, 12 Dec 2022 | €434.3m | €28.7m | -€4,740,218.00 | 10.2x | -91.6x | 15.1x |
| Wed, 09 Nov 2022 | €437.8m | €28.7m | -€4,740,218.00 | 9.1x | -92.4x | 15.3x |
| Fri, 07 Oct 2022 | €411.0m | €23.5m | -€4,296,995.00 | 9x | -95.6x | 17.5x |
| Sun, 04 Sep 2022 | €445.3m | €10.0m | -€15,218,052.00 | 12.5x | -29.3x | 44.6x |
| Tue, 02 Aug 2022 | €440.6m | €10.0m | -€15,218,052.00 | 12.7x | -29x | 44.1x |
| Thu, 30 Jun 2022 | €453.6m | €10.0m | -€15,218,052.00 | 12.6x | -29.8x | 45.4x |
| Sat, 28 May 2022 | €442.9m | €10.0m | -€15,218,052.00 | 12.8x | -29.1x | 44.3x |
| Mon, 25 Apr 2022 | €421.5m | €10.0m | -€15,218,052.00 | 13.1x | -27.7x | 42.2x |
Price to Earnings Ratio
-27.7x
Current Industry PE
- There are only 3 companies in the Italian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 102% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare industry?
| IT Market | 4.64% | |
| Healthcare | 2.84% | |
| Biotech | 5.11% | |
| Biotech | 5.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €20.70 | 5.1% +€40.3m | 13.1% | PE18.4x | |
| UBM Ulisse Biomed | €0.78 | 7.1% +€1.3m | -40.9% | PS24.9x | |
| ARBS Arterra Bioscience | €2.24 | 4.7% +€665.8k | 17.9% | PE11.1x |